A carregar...
Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study
PURPOSE: The immune checkpoint inhibitor is approved for breast cancer treatment, but the low expression of PD-L1 limits the immunotherapy. CD155 is another immune checkpoint protein in cancers and interacts with ligands to regulate immune microenvironment. This study is aimed at investigating the e...
Na minha lista:
| Publicado no: | J Immunol Res |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201814/ https://ncbi.nlm.nih.gov/pubmed/32411795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/3948928 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|